A bill to amend the Controlled Substances Act to prohibit the knowing possession of a pill press mold with intent to manufacture in violation of such Act a counterfeit substance in schedule I or II in a capsule, tablet, and other form intended for distribution, and for other purposes.

Bill 118 s 4355, also known as the Pill Press Anti-Counterfeiting Act of 2021, aims to amend the Controlled Substances Act to address the issue of counterfeit substances being manufactured using pill press molds. The bill specifically targets individuals who knowingly possess a pill press mold with the intent to manufacture counterfeit substances in schedule I or II, such as opioids or other dangerous drugs.

The bill prohibits the possession of pill press molds for the purpose of creating counterfeit substances in capsule, tablet, or other forms intended for distribution. This measure is intended to crack down on the illegal production and distribution of counterfeit drugs, which pose serious risks to public health and safety.

In addition to prohibiting the possession of pill press molds for illicit purposes, the bill also includes provisions for enforcement and penalties for those found in violation. By strengthening regulations and penalties related to the manufacturing of counterfeit substances, the bill aims to deter individuals from engaging in this illegal activity and protect the public from the dangers associated with counterfeit drugs. Overall, Bill 118 s 4355 seeks to address the growing issue of counterfeit substances being produced using pill press molds by implementing stricter regulations and penalties for those involved in this illegal activity. By targeting individuals who knowingly possess pill press molds for illicit purposes, the bill aims to protect public health and safety and prevent the distribution of dangerous counterfeit drugs in the United States.